Hedgehog/GLI1 activation leads to leukemic transformation of myelodysplastic syndrome in vivo and GLI1 inhibition results in antitumor activity

Oncogene
Bonnie W LauLukasz P Gondek

Abstract

Myelodysplastic syndromes (MDSs) are stem cell disorders with risk of transformation to acute myeloid leukemia (AML). Gene expression profiling reveals transcriptional expression of GLI1, of Hedgehog (Hh) signaling, in poor-risk MDS/AML. Using a murine model of MDS we demonstrated that constitutive Hh/Gli1 activation accelerated leukemic transformation and decreased overall survival. Hh/Gli1 activation resulted in clonal expansion of phenotypically defined granulocyte macrophage progenitors (GMPs) and acquisition of self-renewal potential in a non-self-renewing progenitor compartment. Transcriptome analysis of GMPs revealed enrichment in gene signatures of self-renewal pathways, operating via direct Gli1 activation. Using human cell lines we demonstrated that in addition to canonical Hh signaling, GLI1 is activated in a Smoothened-independent manner. GLI1 knockdown or inhibition with GANT61 resulted in decreased proliferation and clonogenic potential. Our data suggest that GLI1 activation is frequent in MDS during disease progression and inhibition of GLI1 is an attractive therapeutic target for a subset of patients.

References

Jul 25, 1997·Cell·A Ruiz i Altaba
Aug 13, 2004·The New England Journal of Medicine·Catriona H M JamiesonIrving L Weissman
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Craig D PeacockWilliam Matsui
Aug 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Luca MalcovatiMario Cazzola
Sep 19, 2007·Molecular and Cellular Biology·Enrique C TorchiaSuzanne J Baker
Dec 18, 2007·Oncogene·J P ZwernerW A May
Oct 4, 2008·Blood·Ying JiangJaroslaw P Maciejewski
Feb 5, 2009·The Journal of Biological Chemistry·Elspeth BeauchampAykut Uren
Oct 28, 2009·PloS One·Jay JooWilliam A May
Nov 6, 2009·The New England Journal of Medicine·Ayalew Tefferi, James W Vardiman
Oct 5, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roland B WalterElihu H Estey
Jun 8, 2012·The New England Journal of Medicine·Aleksandar SekulicAxel Hauschild
Jun 22, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ross McMillan, William Matsui
Mar 13, 2014·Cancer Treatment Reviews·Jillian BrechbielAlex A Adjei
Jan 13, 2015·Nature Communications·Moritz GerstungJacqueline Boultwood
Mar 7, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jasmin WellbrockWalter Fiedler
Jun 13, 2015·Science Translational Medicine·Yiting LimWilliam Matsui
Aug 22, 2015·American Journal of Hematology·Guillermo Garcia-Manero
Aug 22, 2015·Haematologica·Juliana M Xavier-FerrucioPatricia Favaro
Sep 12, 2015·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Hyo-Jin KangJin Wook Chung
Jan 23, 2016·Developmental Biology·Randy RinguetteValerie A Wallace
Mar 24, 2016·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Bing LongQuentin Liu
Dec 20, 2016·Nature Genetics·Hideki MakishimaJaroslaw P Maciejewski

❮ Previous
Next ❯

Methods Mentioned

BETA
MDS
transgenic
flow cytometry
xenograft
PCR
fluorescence-activated cell sorting

Software Mentioned

R
Gene Set Enrichment Analysis ( GSEA )
GSEA
FlowJo

Related Concepts

Related Feeds

CZI Human Cell Atlas Seed Network

The aim of the Human Cell Atlas (HCA) is to build reference maps of all human cells in order to enhance our understanding of health and disease. The Seed Networks for the HCA project aims to bring together collaborators with different areas of expertise in order to facilitate the development of the HCA. Find the latest research from members of the HCA Seed Networks here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.